Does Rallies track congressional trades in HUM?

Yes. Rallies tracks politician and congressional stock disclosures for HUM, including reported purchases, sales, dates, owners, and trade amounts when available.

Is HUM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HUM. It does not provide personalized investment advice.

HUM (Humana) Stock Analysis - Politician Trades

Humana (HUM) is a publicly traded Healthcare sector company. As of May 20, 2026, HUM trades at $307.98 with a market cap of $36.74B and a P/E ratio of 32.86. HUM moved -1.34% today. Year to date, HUM is +17.42%; over the trailing twelve months it is +25.56%. Its 52-week range spans $163.11 to $324.38. Analyst consensus is neutral with an average price target of $241.18. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded HUM stock?

Recent politician trading activity in HUM includes disclosures from Julia Letlow, Gilbert Cisneros, Michael McCaul, Lisa McClain, and Julia Letlow. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

HUM Key Metrics

Key financial metrics for HUM
Metric	Value
Price	$307.98
Market Cap	$36.74B
P/E Ratio	32.86
EPS	$9.39
Dividend Yield	0.89%
52-Week High	$324.38
52-Week Low	$163.11
Volume	589.38K
Avg Volume	0
Revenue (TTM)	$137.20B
Net Income	$1.15B
Gross Margin	0.00%

Congressional Trades in HUM

Julia Letlow sale HUM on Feb 10, 2026 (amount: $15.00K).
Gilbert Cisneros sale HUM on Nov 12, 2025 (amount: $15.00K).
Michael McCaul sale HUM on Nov 4, 2025 (amount: $50.00K) for Spouse.
Lisa McClain purchase HUM on Sep 25, 2025 (amount: $15.00K) for Spouse.
Julia Letlow purchase HUM on Aug 8, 2025 (amount: $15.00K).

Latest HUM News

Deutsche Bank Doubles Humana Price Target to $441, Cites 2026 Rebound — May 20, 2026
Humana Shares Outperform Healthcare Peers as Market Dips — May 12, 2026
Humana jumps as Q1 results and reaffirmed 2026 outlook drive analyst re-ratings — May 6, 2026
Humana Adds 50,000 Medicaid Members, Issues $1B Notes as Medicare Advantage Margins Set to Double — Apr 30, 2026
Humana Q1 EPS $10.31 Beats Estimates, Benefit Ratio at 89.4% — Apr 29, 2026

Recent HUM Insider Trades

Shetty Sanjay K bought 810 (~$150.02K) on Feb 23, 2026.

HUM Analyst Consensus

20 analysts cover HUM: 0 strong buy, 6 buy, 12 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $241.18.

Common questions about HUM

Which politicians traded HUM stock?: Recent politician trading activity in HUM includes disclosures from Julia Letlow, Gilbert Cisneros, Michael McCaul, Lisa McClain, and Julia Letlow. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in HUM?: Yes. Rallies tracks politician and congressional stock disclosures for HUM, including reported purchases, sales, dates, owners, and trade amounts when available.
Is HUM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HUM. It does not provide personalized investment advice.